Genetics & Genomics
IS1- or IS10- activated AcrEF efflux pump may relay AcrAB in serovar Typhimurium
Published in Blood Weekly, April 7th, 2005
"High-level fluoroquinolone (FQ) resistance in Salmonella enterica serovar Typhimurium phage type DT204 has been previously shown to be essentially due to both multiple target gene mutations and active efflux by the AcrAB-TolC efflux system.
"In this study we show that in intermediatly resistant acrB-inactivated serovar Typhimurium DT204 mutants, high-level resistance to FQs can be restored on in vitro selection with FQs," researchers in France report.
"In each FQ- resistant mutant selected from serovar Typhimurium DT204 acrB mutant strains,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-04-07)
More Articles from Blood Weekly
- Bioartificial Liver
Bioreactor developed that supports bioartificial liver - Embryonic Stem Cell Research
Repository stores embryonic stem cell lines with genetic disorders - Stem Cell Transplantation
Chronic GVHD risk increased in patients with HLA class I mismatched donors - Stem Cell Transplantation
High plasmacytoid dendritic cell recovery improves overall survival after ASCT - Tissue Engineering
Hyaluronan gels useful for tissue engineering of aortic heart valves - Acinetobacter Infection
Risk factors identified for multidrug-resistant A. baumannii infection - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
